Heterogeneity of systemic extra-nodal Epstein-Barr virus-associated lympho-histiocytic tumor - Ten autopsy cases of human immunodeficiency virus-negative Japanese

Pathology Research and Practice

Volumn 193, Issue 4, 1997, Pages 257-265

  Ohshima, Koichi ^a   Kobari, Shinichi ^a   Kuroiwa, Shigekazu ^b   Nakanishi, Kazuo ^c   Shibuya, Tunefumi ^b   Nagafuchi, Seiho ^d   Suzumiya, Junji ^a   Takeshita, Morishige ^a   Kikuchi, Masahiro ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b HAMANOMACHI HOSPITAL   (Japan)

^c Department of Pathology   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

Epstein Barr virus (EBV); Extra nodal lympho histiocytic tumor

Indexed keywords

ADOLESCENT; ADRENAL GLAND; ADULT; AGED; ARTICLE; AUTOPSY; B CELL LYMPHOMA; BONE MARROW; BRAIN; CLINICAL ARTICLE; DISEASE COURSE; DISSEMINATED INTRAVASCULAR CLOTTING; EPSTEIN BARR VIRUS; FEMALE; GENOTYPE; HISTIOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; INTESTINE; JAPAN; KIDNEY; LIVER; LIVER DYSFUNCTION; LUNG; LYMPHOID CELL; MALE; MALIGNANT HISTIOCYTOSIS; NOSE CAVITY; PANCYTOPENIA; PHAGOCYTOSIS; RETROSPECTIVE STUDY; SPLEEN; T CELL LYMPHOMA;

EID: 0030754427     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(97)80002-7     Document Type: Article

References (33)

1. Bayliss GJ, Wolf H (1980) Epstein-Barr virus-induced cell fusion. Nature 287: 164-165
2. Delecluse HJ, Raphael M, Magaud JP, et al (1993) Variable morphology of human immunodeficiency-associated lymphomas with c-myc rearrangements. The French Study Group of Pathology for human immunodeficiency virus-associated tumors. Blood 82: 552-563
3. Dreyer ZE, Dowell BL, Chen H, Hawkins E, McClain KL (1991) Infection-associated hemophagocytic syndrome: evidence for Epstein-Barr virus gene expression. Am J Pediatr Hematol Oncol 13: 476-481
4. Falini B, Pileri S, Solas ID, Martelli MF, Mason DY, Delsol G, Gatter KC, Fagioli M (1990) Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood 75: 434-444
5. Ferry JA, Sklar J, Zukerberg LR, Harris NL (1991) Nasal lymphoma: a clinicopathologic study with immunophenotypic and genotypic analysis. Am J Surg Pathol 15: 268-279
6. Fingeroth JD, Weiss JJ, Tender TF, Strominger JL, Biro PA, Fearon DT (1984) Epstein-Barr virus receptor of human B-lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci USA 81: 4510-4514
7. Griffiths GM, Mueller C (1991) Expression of perform and granzymes in vivo: potential diagnostic markers for activated cytotoxic cells. Immunology Today 12: 415-419
8. Hamilton-Dutoit SJ, Pallesen G, Franzmann MB, Karkow J, Black F, Skinhoj P, Pedersen C (1991) AIDS-related lymphomas. Histolpathology, immunophenotype and association with Epstein-Barr virus as demonstrated by in situ necleic acid hybridization. Am J Pathol 138: 149-163
9. Hanto DW, Gajl-Peczalska KJ, Frizzera G, Arthur DC, Balfour HH, McClain K, Simmons RL, Najarian JS (1983) Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative disease occurring after renal transplantation. Clinical, pathologic, and virologie findings and implications for therapy. Ann Surg 198: 356-369
10. Herbst, H, Dallenbach F, Hummel M, Niedobitek G, Pileri S, Müller-Lantzsch N, Stein H (1991) Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad USA 88: 4766-4770
11. Ho FCS, Srivastava G, Loke SL, Ng RP, Khoo RKK (1990) Presence of clonal Epstein-Barr virus in nasal lymphomas of B and T-cell type. Hematol Oncol 8: 271-281
12. Hummel M, Anagnostopoulos I, Korbjuhn P, Stein H (1995) Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types. J Pathol 175: 262-271
13. Kawa-Ha K, Ishihara S, Ninomiya T, Yumura-Yagi K, Hara J Murayama F, Tawa A, Hirai K (1989) CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 84: 51-55
14. Kobari S, Ohshima K, Sumiyoshi Y, Yoneda S, Takeshita M, Kikuchi M (1996) Analysis of the Epstein-Barr viral genome in so-called malignant histiocytosis syndrome. Pathology International 46: 355-363
15. Korbjuhn P, Anagnostopoulos I, Hummel M, Tiemann M, Dallenbach F, Parwaresch MR, Stein H (1993) Frequent latent Epstein-Barr virus infection of neoplastic T cells and bystander B-cells in human immunodeficiency virus-negative European peripheral pleomorphic T-cell lymphomas. Blood 82: 217-223
16. Krenacs L, Raffeld M, Jaffe ES (1995) Site-specific cytotoxic antigen expression in peripheral T-cell lymphoma. Path Res Pract 191: 703-709
17. Lipford EH, Margoick JB, Longo DL, Fauci AS, Jaffe ES (1988) Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferations. Blood 72: 1674-1681
18. Medeiros LJ, Jaffe ES, Chen YY, Weis LM (1992) Localization of Epstein-Barr viral genomes in angiocentric immunoproliferative lesions. Am J Surg Pathol 16: 439-447
19. Ohshima K, Fujisaki T, Nagafuchi S, Niho Y, Kobari S, Kikuchi M (1995) Malignant histiocytosis derived from a common histiocyte clone in a patient with chronic Epstein-Barr virus infection. Leukemia and Lymphoma 17: 355-360
20. Ohshima K, Kikuchi M, Mizuno S, Akashi K, Moriyama K, Yoneda S, Takeshita M, Shibata T (1995) Hepatosinusoidal leukemia/lymphoma containing of Epstein-Barr virus-containing natural killer cell leukemia/lymphoma and T-cell lymphoma; mimicking malignant histiocytosis. Hematological Oncology 13: 83-97
21. Ott G, Ott M, Feller AC, Seidl S, Muller-Hermelink HK (1992) Prevalence of Epstein-Barr virus DNA in different T-cell lymphoma entites in European population. Int J Cancer 51; 562-567
22. Pileri S, Mazza P, Rivano MT, et al. (1985) Malignant histiocytosis (true histiocytic lymphoma) clinicopathological study of 25 cases. Histopathology 9: 905-920
23. Raab-Traub N, Flynn K (1986) The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47: 883-889
24. Rooney CM, Smith CA, Ng CYC, Loftin S, Li C, Krance RA, Brenner MK, Heslop HE (1995) Use of gene-modified virus specific T lymphocytes to control Epstein-Barr virus related lymphoproliferation. Lancet 345: 9-13
25. Rowe M, Lear AL, Croom-Carter D, Davies AH, Rickinson AB (1992) Three pathways of Epstein-Barr virus gene activation from ENBA1 positive latency in B lymphocytes. J Virol 66: 122-139
26. Sasajima Y, Yamabe H, Kobashi Y, Hirai K, Mori S (1993) High expression of the Epstein-Barr virus latent protein EB nuclear antigen-2 on pyothorax-associated lymphomas. Am J Pathol 143: 1280-1285
27. Shitata D and Weiss LM (1992) Epstein-Barr virus associated gastric adeno-carcinoma. Am J Pathol 140: 769-774
28. Simrell CR, Margolick JB, Crabtree GR, Cossman J, Fauci AS, Jaffe ES (1985) Lymphokine-induced phagocytosis in angiocentric immunoproliferative lesion (AIL) and malignant lymphoma arising in AIL. Blood 65: 1469-1476
29. SU IJ, Hsu YH, Lin MT, Cheng AL, Wang CH, Weiss LM (1993) Epstein-Barr virus-containing T-cell lymphoma presents with hemophagocytic syndrome mimicking malignant histiocytosis. Cancer 72: 2019-2027
30. Tokunaga M, Imai S, Uemura Y, Tokudome T, Osato T, Sato E (1993) Epstein-Barr virus in adult T-cell leukemia/lymphoma. Am J Pathol 143: 1263-1269
31. Weiss LM, Movahed LA, Warnke RA, Sklar J (1989) Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 32: 502-506
32. Weiss LM, Trela MJ, Cleary ML, Turner RR, Warnke RA, Sklar J (1985) Frequent immunoglobulin and T-cell receptor gene rearrangements in "histiocytic" neoplasms. Am J Pathol 121: 369-373
33. Wilson MS, Weiss LM, Gatter KC, Mason DY, Dorfman RF, Warnke RA (1990) Malignant histiocytosis. A reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies. Cancer 66: 530-536